Search

 
Reset

Go to project search
Go to scientific publication search
Go to staff list

551 results:
Search results 251 until 260 of 551
251. [BIPS Project] Drug interactions and the risk of serious hemorrhage in patients receiving phenprocoumon  
URL: /en/research/projects/detail-view.html?projID=335&cHash=518d947f32cad43b7292c4f58b20f134
Date: 01-01-07
Vitamin K antagonists (VKAs) have been widely used for more than 50 years for oral anticoagulation and the prevention of venous and arterial thromboembolic diseases. Atrial fibrillation is a common…  
252. [BIPS Project] Drug safety in children and adolescents (a) off-label use and safety of neuroleptic and antidepressive medication, (b) safety of psycho-stimulant therapy  
URL: /en/research/projects/detail-view.html?projID=475&cHash=136233cc6b32a1b221c0abfee0baa5e3
Date: 01-11-12
In paediatric populations, drugs are frequently prescribed off-label (not in accordance with the approved age range or indications). This is also true for psychotropic drugs. Studies found that up to…  
253. [BIPS Project] Drug utilisation study of eliglustat for the treatment of Gaucher disease type 1 in Europe using electronic healthcare records  
URL: /en/research/projects/detail-view.html?projID=918&cHash=d876d3358dfbd42e2702cd0b2b6dc02e
Date: 30-06-21
Gaucher disease (GD) is a rare genetic disorder from the group of lysosomal storage disorders. It is characterized by the buildup of glucocerebroside in certain organs and tissues, particularly the…  
254. [BIPS Project] Drug utilization study to evaluate the effectiveness of additional risk minimization measures for upadacitinib in the treatment of atopic dermatitis  
URL: /en/research/projects/detail-view.html?projID=1058&cHash=7c786a506c59206d88343acad19a145c
Date: 15-02-23
Upadacitinib (Rinvoq®) is a so-called Januskinase (JAK)-inhibitor which is approved for the treatment of chronic rheumatic diseases such as ulcerative colitis, rheumatic arthritis and atopic…  
255. [BIPS Project] Eating healthy made easy - Developing ways to support a healthy diet for people with mental disabilities in residential homes  
URL: /en/research/projects/detail-view.html?projID=838&cHash=bfecb854041d1cb8c044a4effd2b353a
Date: 01-12-19
[FETT]Aim of the project[/FETT] The project aimed to improve the nutritional situation of people with disabilities in the setting "stationary living" of Lebenshilfe Bremen…  
256. [BIPS Project] Effects of bariatric procedures  
URL: /en/research/projects/detail-view.html?projID=809&cHash=076678a98193c50547e913fa96dbacef
Date: 01-04-20
Obesity is a common disease in Germany. People with obesity suffer from a variety of comorbidities such as respiratory diseases, cardiovascular diseases and skin diseases, but also from psychological…  
257. [BIPS Project] Environmental and behavioral interventions for the prevention of childhood overweight - Development of a system for documentation and evaluation  
URL: /en/research/projects/detail-view.html?projID=662&cHash=050cf3dbb4fee062c77181351cbfab02
Date: 01-02-16
The ‚DEVACHECK’-project is funded by the Federal Centre for Health Education (BZgA). The focus of this study lies on interventions for the prevention of childhood overweight targeting the environment…  
258. [BIPS Project] Epidemiological database study investigating the risk of diabetic complications in type 2 diabetes patients treated with different antidiabetics  
URL: /en/research/projects/detail-view.html?projID=398&cHash=2cbe4271b37dfe11aa6d8b77860f03be
Date: 01-03-10
Cardiovascular diseases are the most common comorbidities in diabetics and account for the high morbidity and mortality among these patients. Several studies emphasised the role of a proper…  
259. [BIPS Project] Epidemiological methods and experiences in research projects on child and adolescent health  
URL: /en/research/projects/detail-view.html?projID=835&cHash=25a7b2f6ca2a434f686e1956adc6df85
Date: 01-01-20
In this project, both partners from the Peking University in China and the Leibniz Institute for Prevention Research and Epidemiology - BIPS in Germany will mutually investigate risk factors for…  
260. [BIPS Project] Epidemiological study to investigate the utilization of the new anticoagulant rivaroxaban after market launch in Germany  
URL: /en/research/projects/detail-view.html?projID=421&cHash=ba6647a2ce1f2b7f62eaa0c6be5acc73
Date: 01-12-10
Rivaroxaban (Xarelto®) is a direct oral anticoagulant (DOAC) approved by the European Medicine Agency (EMA) in 2008 for the prevention of venous thromboembolism in patients undergoing elec-tive hip…  
Search results 251 until 260 of 551